Division of Endocrinology, Diabetes & Metabolism Research
Faculty members in NYU Langone’s Department of Endocrinology advance the field’s body of knowledge through lab and clinical research. Our team’s current areas of interest include diabetes, gender-affirming hormone therapy, lipid metabolism, male hypogonadism, obesity and adipose biology, pituitary and adrenal disease, and thyroid disease.
Search for active clinical trials in the Division of Endocrinology, Metabolism, and Diabetes.
Our faculty and members of their research teams conduct groundbreaking clinical and lab research in diabetes.
Diabetes Clinical Research
The following faculty members conduct clinical research in diabetes. In addition, we have a strong relationship with researchers and programs at NYU Long Island School of Medicine and NYU Langone Hospital—Long Island.
Jeffrey S. Berger, MD
Michael Bergman, MD
Caroline S. Blaum, MD
Antonio J. Convit, MD
Ira J. Goldberg, MD
Lauren H. Golden, MD
Akankasha Goyal, MD
Jonathan Newman, MD, MPH
Stephen B. Richardson, MD
Melissa Sum, MD
Diabetes Lab Research
The following division members, as members of the Diabetes Research Program, conduct laboratory research in diabetes.
Julie De Bermont is a research technician in Dr. Ira Goldberg’s lab. She conducts single-cell analysis of human and mouse white blood cells.
Brenda Dorcely, MD, is a postdoctoral fellow and member of Dr. Goldberg’s lab. She studies the effects of weight reduction and improvement of diabetes on white blood cells.
Lipid Metabolism Research
Researchers in the Division of Endocrinology, Diabetes, and Metabolism investigate a wide range of issues related to lipid metabolism. With our colleagues at the Center for the Prevention of Cardiovascular Disease, our researchers hold a weekly combined clinical and research conference that covers issues related to clinical lipid disorders as well as new therapies and clinical trials. In addition, we collaborate as recipients of an American Heart Association Diabetes and Vascular Disease Repair in Women and Men, or REPAIR, grant, and present a yearly cardiovascular risk reduction continuing medical education program, half of which focuses on diabetes treatment.
Members of Dr. Hussain’s laboratory at NYU Langone Hospital—Long Island actively collaborate with our division faculty who conduct lipid research. Research conferences, which include investigators from both sites, are conducted via video. In addition, we hold a yearly combined research retreat.
Debapriya Basu, PhD, is a research assistant professor and a member of Dr. Goldberg’s lab. She studies liver production of low-density lipoproteins (LDL) and conversion of very low–density lipoproteins to LDL. In addition, she investigates the metabolic effects of new triglyceride-reducing therapies.
Ainara Gonzáles Cabodevilla, PhD, is a postdoctoral fellow and member of Dr. Goldberg’s lab. She studies uptake of chylomicrons into endothelial cells.
Lesley-Ann Huggins is manager of Dr. Goldberg’s lab.
Nouran Ibrahim is a research technician in Dr. Goldberg’s lab. She performs editing and genetic analysis of animal models.
Dimitrios Nasias, PhD, is a postdoctoral fellow and member of Dr. Goldberg’s lab. He studies genetic analysis of how changes in lipid uptake pathways affect macrophage polarity and how weight loss affects circulating white blood cells in humans.
Babajide Oluwadare is an MD/PhD student at the Vilcek Institute of Graduate Biomedical Sciences and a member of Dr. Goldberg’s lab. He studies how altering lipid uptake pathway affects heart triglyceride accumulation using models of heart lipotoxicity.
Cecilia Ono is the division administrator and administrator of Dr. Goldberg’s lab.
Ni-Huiping Son, MD, PhD, is a research associate and member of Dr. Goldberg’s lab who studies development of genetically altered mouse models to assess lipid metabolism.
Yunying Yu is a senior research technician in Dr. Goldberg’s lab.
Gender-Affirming Hormone Therapy Research
Members of our faculty collaborate with colleagues in plastic surgery, gynecology, urology, reproductive endocrinology, and internal medicine in NYU Langone’s multispecialty transgender program.
Obesity and Adipose Biology Research
Members of our division conduct research investigating the biology of fat cells as well as their relationships to obesity, heart disease, and other conditions.
Paola DiMarzio, PhD, joined NYU Langone as a fellow in the lab of Elisabetta Mueller, PhD, in 2018 and is currently working on projects aimed at understanding the role of ZNF638 and HSF1 in thermogenic adipocyte functionality.
Luce Perie, PhD, joined Dr. Mueller’s lab as a fellow at NYU Langone in 2017. Her current project seeks to identify new transcription factors and cofactors involved in the regulation of thermogenic adipose tissues. Specifically, her work is now centered around the role of the zinc finger protein ZNF638, newly characterized by Dr. Mueller’s team as a transcriptional cofactor, in the regulation of thermogenic tissue functionality.
Michael Verano is a research technician and lab manager in Dr. Alemán’s lab.
Narendra Verma, PhD, joined Dr. Mueller’s laboratory as a fellow in 2017, where he is currently working on the identification of the transcriptional circuitry regulated by the Heat Shock Factor-1 (HSF1) in brown and beige fat tissues.
Male Hypogonadism Research
Our faculty seek to better understand how male hypogonadism affects other endocrine disorders, such as obesity and type 2 diabetes.
Pituitary and Adrenal Disease Research
Members of our faculty conduct research investigating silent corticotroph adenomas, treatments for acromegaly, and hypophysitis.
Thyroid Disease Research
Researchers in our division develop tools to diagnose thyroid diseases, including thyroid cancer, and investigate new therapies.
Recent Research Grants
Grants from a variety of sources allow us to maintain our reputation as research leaders in the field. In addition to the grants below, our division shares a National Institutes of Health (NIH)–funded T32 training program with NYU Langone’s Leon H. Charney Division of Cardiology.
American Heart Association Strategically Focused Research Networks Grants
In December 2019, a team led by our division director, Ira J. Goldberg, MD, received a $3.03 million American Heart Association (AHA) Diabetes and Vascular Disease Repair in Women and Men, or REPAIR, grant. The award enables Dr. Goldberg and his team to study why drugs that lower cholesterol are less effective in reducing cardiovascular disease events in people who have diabetes. Read more about this grant.
REPAIR also offers a postdoctoral training program directed by Dr. Goldberg. Johns Hopkins, Brigham and Women’s Hospital, and a University of Iowa–Massachusetts General Hospital collaboration are also part of the AHA’s Strategically Focused Research Network in Cardiometabolic Disease focusing on type 2 diabetes.
In 2017, NYU Langone received a grant to become an AHA Center for Obesity Research. Our obesity network, called IGNITION (InvestiGating Novel obesIty soluTIONs), encompasses three projects: a basic science project studying the role of the receptor for advanced glycation end products (RAGE) in adipose development led by Ann Marie Schmidt, MD; a human translational project that assesses how weight loss affects inflammation, led by Dr. Goldberg and Dr. Alemán with collaborators in the Center for the Prevention of Cardiovascular Disease, Department of Population Health, Department of Surgery, and Division of General Internal Medicine and Clinical Innovation; and a population health project, led by Mary A. Sevick, ScD, that studies how the microbiome affects glucose variability and how and whether this predicts response to weight loss. Learn more about this grant and the AHA’s Strategically Focused Research Networks.